Bioequivalence between novel ready-to-use liquid formulations of the recombinant human GH Omnitrope and the original lyophilized formulations for reconstitution of Omnitrope and Genotropin.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Two strengths of a novel ready-to-use liquid preparation of the recombinant human GH (rhGH) Omnitrope were developed to increase the convenience for the patients.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Eur. J. Endocrinol.

Title: European journal of endocrinology

Publisher: Bioscientifica

ISSN (Electronic): 1479-683X

ISSN (Print): 0804-4643

Publication date (Electronic): Jun 2010

Volume: 162

Issue: 6

Affiliations

[1 ] Clinical Pharmacology Unit, Department of Pharmacology, Hospital of the University of Cologne, Cologne, Germany.

Article

Publisher Item ID: EJE-09-1101

DOI: 10.1530/EJE-09-1101

PubMed ID: 20332125

SO-VID: bccfef78-83eb-49c4-92d8-1322698d00f6

History

Data availability:

Comments

Comment on this article

scite_

Cited by 4

See all cited by